This is an exclusive post for munKNEE.com visitors of the performance of the stocks within the pot, psychedelic and plant-based stock portfolios YTD, for the month of October and last week. Share the information with your financial advisor/portfolio manager as he has never seen such information in such a comparative analysis.
By Lorimer Wilson, Managing Editor of munKNEE.com – A unique financial site for those with sore eyes and inquisitive minds. Sign up in the top right hand corner of this page to receive the weekly Market Intelligence Report of the latest articles posted on the site (see sample here).
The articles below were written for posting exclusively on TalkMarkets. Go here for my site profile and a recap of all my articles posted there.
16 of the 25 stocks in the Pure-Play Pot Stock Portfolio are up YTD. This article identifies those stocks and their percentage increases over the past 11 months.
Thirty-one bio-pharmaceutical companies are now involved in the research and development of psychedelic compounds to treat mental health issues.
Only 6 pure-play plant-based stocks are currently listed on the various Canadian and American stock exchanges and this article provides introductory paragraphs, and links, to my recent exclusive articles on TalkMarkets on each company followed by their stock performances for the week ended November 27th.
About Lorimer Wilson
Lorimer Wilson is an economic & financial commentator on economics, personal finance and investing in gold and silver and cannabis, psychedelic and plant-based stock sectors. He is the Managing Editor of munKNEE.com, a site that provides a selection of the internet’s best finance articles in an edited, reformatted and abridged format to ensure a fast and easy read.